Seratrodast
|
|
|
- CAS-Nr.
- 112665-43-7
- Englisch Name:
- Seratrodast
- Synonyma:
- Bronic;CS-324;aa-2414;Bronica;Seretra;ABT-001;Serabenast;CCRIS 8939;Seratrodast;50MG/200MG/1G
- CBNumber:
- CB8284400
- Summenformel:
- C22H26O4
- Molgewicht:
- 354.44
- MOL-Datei:
- 112665-43-7.mol
|
Seratrodast Eigenschaften
- Schmelzpunkt:
- 118-120°C
- Siedepunkt:
- 522.3±49.0 °C(Predicted)
- Dichte
- 1.140±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Store in freezer, under -20°C
- L?slichkeit
- Chloroform (Slightly), Methanol (Slightly)
- pka
- 4.76±0.10(Predicted)
- Aggregatzustand
- Yellow-orange solid.
- Farbe
- Pale Orange to Yellow
- Merck
- 14,8459
- CAS Datenbank
- 112665-43-7(CAS DataBase Reference)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| RTECS-Nr. |
DA1600050 |
|
|
| HS Code |
2918.30.3000 |
|
|
| Bildanzeige (GHS) |
|
| Alarmwort |
Warnung |
| Gefahrenhinweise |
| Code |
Gefahrenhinweise |
Gefahrenklasse |
Abteilung |
Alarmwort |
Symbol |
P-Code |
| H361 |
Kann vermutlich die Fruchtbarkeit beeintr?chtigen oder das Kind im Mutterleib sch?digen. |
Reproduktionstoxizit?t |
Kategorie 2 |
Warnung |
|
P201, P202, P281, P308+P313, P405,P501 |
|
| Sicherheit |
| P201 |
Vor Gebrauch besondere Anweisungen einholen. |
| P202 |
Vor Gebrauch alle Sicherheitshinweise lesen und verstehen. |
| P280 |
Schutzhandschuhe/Schutzkleidung/Augenschutz tragen. |
| P308+P313 |
BEI Exposition oder falls betroffen: ?rztlichen Rat einholen/?rztliche Hilfe hinzuziehen. |
| P405 |
Unter Verschluss aufbewahren. |
| P501 |
Inhalt/Beh?lter ... (Entsorgungsvorschriften vom Hersteller anzugeben) zuführen. |
|
Seratrodast Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Seratrodast, a novel benzoquinone derivative, is the first thromboxane A
2
(TxA
2) receptor antagonist to reach the market. It is orally active for the treatment of
bronchospastic disorders such as asthma. TxA
2, a metabolite of the arachidonate
cascade, is involved in several cardiovascular and respiratory diseases through its
potent biological effects on platelet aggregation and constriction of vascular and
respiratory smooth muscles. Seratrodast potently inhibits platelet aggregation and
bronchoconstriction induced by a TxA
2 mimic and by a variety of spasmogenic
prostanoids including PGF
2α, PGD
2 and 9α,11β-PGF
2. Seratrodast shows excellent
efficacy in asthma and has been reported to be potentially useful in hyper-responsive
disorder. The R-(+)- seratrodast was reported to be the active isomer.
Chemische Eigenschaften
Pale Orange Solid
Biologische Aktivit?t
Thromboxane A 2 (TP) receptor antagonist. Antiasthmatic agent; inhibits platelet aggregation and bronchoconstriction induced by a TXA 2 mimetic in guinea pigs.
Seratrodast Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Seratrodast Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 236)Lieferanten
112665-43-7()Verwandte Suche:
- 50MG/200MG/1G
- benzeneheptanoic acid, -(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-
- (+-)-7-(3,5,6-trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoicacid
- aa-2414
- beta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-bezeneheptanoicaci
- 5-(2,4,5-trimethyl-3,6,-dioxo-1,4-cyclohexadien-1-yl)benzeneheptanoic acid
- 7-(3,5,6-trimethy1-1,4-benzoquinon-2-y1)-7-phenylheptanoic acid
- 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-1-cyclohexa-1,4-dienyl)heptanoic acid
- Bronica
- Abbott 73001
- Bronic
- (±)-ζ-2，4，5-Trimethyl-3，6-dioxo-1，4-cyclohexadien-1-y1)benzeneheptanoic acid
- 7-(3,6-diketo-2,4,5-trimethyl-cyclohexa-1,4-dien-1-yl)-7-phenyl-enanthic acid
- 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-cyclohexa-1,4-dien-1-yl)heptanoic acid
- 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl)heptanoic acid
- Serabenast
- Seratrodast
- Seratrodast(AA-2414,ABT-001)
- AA-2414;SERETRA;AA2414;AA 2414
- Seretra
- Seratrodast AA 2414
- CS-324
- Seratrodast >
- ABT-001
- Seratrodast USP/EP/BP
- CCRIS 8939
- 112665-43-7
- C22H26O4
- ZAGAM
- API
- Heterocyclic Compounds
- Intermediates & Fine Chemicals
- Pharmaceuticals
